Navigation Links
Statins Gives New Hope for Increased Survival Rate of Heart Failure Patients

Administrating statins to patients with diastolic heart failure increases// the survival rate by 22% compared to patients receiving other drugs.

William C. Little and his research team from Wake Forest University, has found that patients with diastolic heart failure (DHF) treated with statins has better survival rates. The study was done on 137 diastolic heart failure patients published in the Journal Circulation: Journal of the American Heart Association. Diastolic heart failure occurs as the heart does not fully relax and therefore does not fill properly with blood. The mortality occurring due to DHF is 5-8%. Once hospitalized, patients with diastolic heart failure have a 50 percent chance of re-hospitalization within six months. It’s estimated that the cost of treating patients for diastolic heart failure exceeds $3.5 billion a year.

William C. Little reports, "Some patients in the group had been diagnosed with high cholesterol and placed on statin therapy by their doctors. Others in the group whose cholesterol levels were not as high in general, were not placed on statins," Little and his research team found that during the study period, heart failure patients on statin therapy had a risk of death that was 22 percent lower than the patients receiving the other drugs. Even after adjusting for other factors that could have affected the results, such as hypertension or cardiovascular disease, the heart failure patients on statins still fared better.

The better survival of these patients is due to the beneficial effects of statins in DHF patients.

Source : (Newswise)

Further Information on Heart disease from Medindia

Chest pain is a common symptom which can be caused by many different conditions. Some causes of chest pain require prompt medical attention, such as angina, heart attack, or tearing of the aorta. Other causes of chest pain can be evaluated electively, such
'"/>




Page: 1 2

Related medicine news :

1. Statins reduce heart attacks
2. Statins reduce risks for angioplasty patients
3. Statins Found To Be Helpful For Patients With Arthritis
4. Long-Term Benefits Of Statins Questioned
5. Statins Not Effective In Treating Calcific Aortic Stenosis
6. The Effects of Statins Questioned
7. Statins Taken For Reducing Cholesterol Found To Reduce Death Rate Associated With Heart Attack As Well
8. Study Finds No Link Between Statins And Breast Cancer Risk
9. Statins Reduce Deaths And Strokes After Carotid Surgery
10. Statins reduces cardiovascular risk but no cancer risk.
11. Statins Prescribed To Those Who Are At a Risk Of Developing A Heart Disease

Post Your Comments:
(Date:11/27/2009)...ER, N.Y., Nov. 27 Preve...vider and fortunately every year, new vaccines are...do all vaccines boost immunity for the same period...r shots, needed to keep immunity strong? ,, I... the American Academy of Pediatrics, Michael Pichi...
(Date:11/27/2009)... XenaCare Holdings has announced that it has...tion, one of the largest nonprofit organizations d...ducation. , Delray Beach,..., Inc. (OTCBB: XCHO), a company specializing in th...althcare products, has announced today that is has...
(Date:11/27/2009)... , SEATTLE, Nov. 27 Allreci...ord-high Thanksgiving traffic numbers, with more t...ng, providing a clear picture of what was served o...e Thanksgiving meal in 2009 weighed in at 2,225 ca... year,s feast. According to the Allrecipes site, ...
(Date:11/27/2009)... Specialist manufacturers who use medical lo... millions of dollars by bringing in technology par...ng numbers of pro-active medical manufacturers are...pt stage of their projects, ensuring that progress...ses or potentially outdated technology. , ...
(Date:11/26/2009)...ETON, N.J., Nov. 27 The diabetes p...over the next 25 years and annual medical spending...up from $113 billion today, according to a study p... The National Changing Diabetes ® Program (... analysis by a team from the University of Chicago...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4
...an,orthopedic implants company focused on silicon ... Ashok Khandkar, Ph.D., Chief Executive,Officer, a...f Financial,Officer, are scheduled to present at t...Khandkar and Mr. Gallacher will provide a general ...
...A preparation with no,detectable large RNA and fur... developing area of RNAi, ST....s pleased to introduce mirPremier(TM) microRNA Iso...,purifying and enriching miRNA along with other sm...
...ed those with Lou Gehrig,s disease , , THU...ntibiotic minocycline against amyotrophic lateral ...ed because patients taking the drug had a signific...s such as multiple sclerosis, said a report publis...
...aloon will,host a tribute to the late songwriter W...PM to raise research money and awareness for Mesot...much loved and respected troubadour.,Tickets for t...ds from the show will go to The Mesothelioma Appli...
...anxiety from stressful life situations may be more...ast the first six months after the event, accordin...the journal SLEEP. , The study, authored by Jussi...urbed sleep and 2,572 with disturbed sleep, all of...
...,unveil the successor to its unique Xcelodose syst...and vials at the American Association of,Pharmaceu...o (November 11th,-15th, 2007). The new Xcelodose ...nded software functionality. These enhancements w...
Other Medicine News:Health News:Sigma-Aldrich Announces mirPremier(TM) microRNA Isolation Kit for miRNA Purification 2Health News:Sigma-Aldrich Announces mirPremier(TM) microRNA Isolation Kit for miRNA Purification 3Health News:Study Shows Antibiotic Harms ALS Patients 2Health News:Friends of Warren Zevon To Play at Maverick Saloon - Raising Awareness of Asbestos Cancer, Mesothelioma 2Health News:Anxiety linked to sleep disturbances 2Health News:New Generation Xcelodose(R)S Precision Drug Powder Micro-filling System Offers 50% Increased Throughput 2
(Date:11/25/2009)..., NEW YORK, Nov. 25 Reportlinker...s available in its catalogue: ,, Intranasal Dr...tp://www.reportlinker.com/p0164267/Intranasal-Drug... The US intranasal drug delivery market is witness...the delivery of conventional local therapeutic dru...
(Date:11/25/2009)...NTAIN VIEW, Calif., Nov. 25 Chem...clinical data from the Company,s PROTECT-1 (the Pr...ohn,s disease Trial) of Traficet-EN(TM) (CCX282-B)...se demonstrated clinical efficacy with a favorable...strated evidence of clinical efficacy in the reduc...
(Date:11/24/2009)...VINE, Calif., Nov. 24 En...ally invasive treatments for aortic disorders, ann...r discontinue all proceedings in, the patent infri... by Cook, Inc. The motion was filed in the United..., Endologix has requested that the stay remain ...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR NCI EORTC MEETING 14904 1YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR NCI EORTC MEETING 14904 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR NCI EORTC MEETING 14904 3BeamOne LLC to Add New Ebeam Sterilization Service Center 6384 1BeamOne LLC to Add New Ebeam Sterilization Service Center 6384 2Residential design for persons with neurological disability 61642 1Residential design for persons with neurological disability 61642 2Residential design for persons with neurological disability 61642 3
...es,Pharmaceuticals, Inc., (Nasdaq: ALSE ), announ...n the initial stage of the ALTROPANE(R) Parkinson,...cal trial program. This,subject was enrolled at th...er the direction of Principal Investigator Dr. Ray...ment of Neurology., ALTROPANE is a diagnostic mol...
...(TM) shows lifesaving potential -, - HGS on trac...ockpile beginning in 2008...s, Inc. (Nasdaq: HGSI ) today announced that the ...e-saving potential of its human,monoclonal antibod... that a,single dose of ABthrax, administered witho...
Other Medicine Technology:Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 2Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 3Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 4Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 5New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 2New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 3New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 4New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 5New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 6New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 7
CX41 Microscopes
CX31 Microscopes
...designed from the ground-up with ergonomic concern...justable observation tube on the market. Optional ...every user can adjust the microscope to suit their...s the operator maintain an upright, comfortable po...
Eclipse TS100F
Medicine Products: